LGG-27. Molecular implications of mitogen-activated protein kinase pathway inhibition by the MEK inhibitor trametinib in BRAF-fusion-driven pediatric pilocytic astrocytoma

Authors: Romain Sigaud, Anja Stefanski, Florian Selt, Thomas Hielscher, Diren Usta, Daniela Kocher, Daniel Picard, Isabel Büdenbender, Marc Remke, Stefan M Pfister, David T W Jones, Tilman Brummer, Olaf Witt, Till Milde

Published: 2022-06-03

DOI: 10.1093/neuonc/noac079.341

Source: Full article

LGG-27. Molecular implications of mitogen-activated protein kinase pathway inhibition by the MEK inhibitor trametinib in BRAF-fusion-driven pediatric pilocytic astrocytoma

Abstract